|
|
Line 3: |
Line 3: |
| <StructureSection load='6u58' size='340' side='right'caption='[[6u58]], [[Resolution|resolution]] 1.90Å' scene=''> | | <StructureSection load='6u58' size='340' side='right'caption='[[6u58]], [[Resolution|resolution]] 1.90Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[6u58]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6U58 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6U58 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6u58]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6U58 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6U58 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Hybrid , Neutron Diffraction , X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr> |
- | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Beta-lactamase Beta-lactamase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.2.6 3.5.2.6] </span></td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6u58 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6u58 OCA], [http://pdbe.org/6u58 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6u58 RCSB], [http://www.ebi.ac.uk/pdbsum/6u58 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6u58 ProSAT]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6u58 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6u58 OCA], [https://pdbe.org/6u58 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6u58 RCSB], [https://www.ebi.ac.uk/pdbsum/6u58 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6u58 ProSAT]</span></td></tr> |
| </table> | | </table> |
- | <div style="background-color:#fffaf0;">
| + | == Function == |
- | == Publication Abstract from PubMed == | + | [https://www.uniprot.org/uniprot/BLT1_ECOLX BLT1_ECOLX] Has strong cefotaxime-hydrolyzing activity. |
- | The amino-acid sequence of the Toho-1 beta-lactamase contains several conserved residues in the active site, including Ser70, Lys73, Ser130 and Glu166, some of which coordinate a catalytic water molecule. This catalytic water molecule is essential in the acylation and deacylation parts of the reaction mechanism through which Toho-1 inactivates specific antibiotics and provides resistance to its expressing bacterial strains. To investigate the function of Glu166 in the acylation part of the catalytic mechanism, neutron and X-ray crystallographic studies were performed on a Glu166Gln mutant. The structure of this class A beta-lactamase mutant provides several insights into its previously reported reduced drug-binding kinetic rates. A joint refinement of both X-ray and neutron diffraction data was used to study the effects of the Glu166Gln mutation on the active site of Toho-1. This structure reveals that while the Glu166Gln mutation has a somewhat limited impact on the positions of the conserved amino acids within the active site, it displaces the catalytic water molecule from the active site. These subtle changes offer a structural explanation for the previously observed decreases in the binding of non-beta-lactam inhibitors such as the recently developed diazobicyclooctane inhibitor avibactam.
| + | |
| | | |
- | Probing the role of the conserved residue Glu166 in a class A beta-lactamase using neutron and X-ray protein crystallography.,Langan PS, Sullivan B, Weiss KL, Coates L Acta Crystallogr D Struct Biol. 2020 Feb 1;76(Pt 2):118-123. doi:, 10.1107/S2059798319016334. Epub 2020 Jan 24. PMID:32038042<ref>PMID:32038042</ref>
| + | ==See Also== |
- | | + | *[[Beta-lactamase 3D structures|Beta-lactamase 3D structures]] |
- | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
| + | |
- | </div>
| + | |
- | <div class="pdbe-citations 6u58" style="background-color:#fffaf0;"></div>
| + | |
- | == References ==
| + | |
- | <references/>
| + | |
| __TOC__ | | __TOC__ |
| </StructureSection> | | </StructureSection> |
- | [[Category: Beta-lactamase]] | + | [[Category: Escherichia coli]] |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Langan, P S]] | + | [[Category: Langan PS]] |
- | [[Category: Sullivan, B]] | + | [[Category: Sullivan B]] |
- | [[Category: Weiss, K L]] | + | [[Category: Weiss KL]] |
- | [[Category: Hydrolase]]
| + | |